Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION USP

Last updated on 2019-08-28 History
Report ID 76559
Drug Identification Number 02347830
Brand name ROPIVACAINE HYDROCHLORIDE INJECTION USP
Common or Proper name Ropivacaine Hydrochloride Injection USP
Company Name PFIZER CANADA ULC
Active Ingredient(s) ROPIVACAINE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration EPIDURAL
Packaging size 10 x 10mL GVL
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-02-20
Estimated end date 2019-12-20
Actual end date
Shortage status Actual shortage
Updated date 2019-08-28
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2019-08-28 French Compare
v9 2019-08-28 English Compare
v8 2019-05-27 French Compare
v7 2019-05-27 English Compare
v6 2019-04-17 French Compare
v5 2019-04-17 English Compare
v4 2019-03-13 French Compare
v3 2019-03-13 English Compare
v2 2019-02-21 French Compare
v1 2019-02-21 English Compare